ABSTRACT
On March 11, the World Health Organization (WHO) announced that the novel coronavirus disease 2019 (COVID-19) outbreak had become a global pandemic. The symptoms of COVID-19 are well known, and a range of treatments have been used to save lives. However, those who have recovered from COVID-19 may be struggling to mentally cope with what they have experienced physically. They may even develop signs and symptoms of an acute stress response, or post-traumatic stress disorder (PTSD). A question we face in the coming months is how to help survivors of severe COVID-19 recover. Although patients with confirmed or suspected cases of COVID-19, health care workers, and other people are showing signs of psychological problems related to the disease, survivors of previous diseases, health care workers, and front-line employees face a higher risk of infection and are more likely to be depressed, anxious, or even diagnosed with PTSD. Exposure, fear, isolation, loss of income, reduced autonomy, and the inability of health care professionals to cure coronavirus infections contribute to this increased stress. As everyone is vulnerable to COVID-19, providing mental health support will help people maintain their mental health and return to a heathy life more quickly. The objective of this paper is to explore the research progress of post-traumatic stress disorder (PTSD) related to COVID-19. (PsycInfo Database Record (c) 2021 APA, all rights reserved)
ABSTRACT
Since December 2019, there has been an outbreak of a novel coronavirus (COVID-19) infection in Wuhan, China. Meanwhile, the outbreak also drew attention and concern from the World Health Organization (WHO). COVID-19 is another human infectious disease caused by coronavirus. The transmission of COVID-19 is potent and the infection rate is fast. Since there is no specific drug for COVID-19, the treatment is mainly symptomatic supportive therapy. In addition, it should be pointed out that patients with severe illness need more aggressive treatment and meticulous care. Recently, accurate RNA detection has been decisive for the diagnosis of COVID-19. The development of highly sensitive RT-PCR has facilitated epidemiological studies that provide insight into the prevalence, seasonality, clinical manifestations and course of COVID-19 infection. In this review, we summarize the epidemiology and characteristics of COVID-19.